| Financial Year |
March 31 2023 |
| Monetary Funds |
295,574,529.93 |
| Held-for-trading Financial Assets |
51,000,000.00 |
| Notes Receivable |
41,828,619.21 |
| Accounts Receivable |
1,332,989,814.23 |
| Advances to Suppliers |
137,427,921.84 |
| Other Receivables |
148,856,905.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
2,552,015.30 |
| Dividend Receivable |
-- |
| Inventories |
790,198,688.25 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
169,368,040.63 |
| Total Current Assets |
2,968,185,869.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,072,758.31 |
| Long-term Equity Investment |
8,383,927.74 |
| Investment Properties |
67,754,943.16 |
| Fixed Assetes |
446,156,933.40 |
| Under-construction Projects |
84,236,375.25 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
137,217,834.56 |
| R&D expenses |
690,798.78 |
| Goodwill |
89,466,741.71 |
| Long-Term Deferred and Prepaid Expenses |
495,190.59 |
| Deferred Income Tax Assets |
51,883,879.16 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,057,708,499.87 |
| Total Assets |
4,025,894,369.21 |
| Short-Term Loans |
528,475,099.57 |
| Trading Financial liabilities |
-- |
| Notes Payable |
116,144,720.00 |
| Accounts Payable |
326,084,062.01 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
30,313,037.15 |
| Taxes Payable |
28,231,793.33 |
| Interest Payable |
-- |
| Dividend Payable |
3,380,240.98 |
| Other payables |
145,394,903.76 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
45,490,565.86 |
| Other Current Liabilities |
22,879,713.19 |
| Sub-Total of Current Liabilities |
1,433,595,064.26 |
| Long-term Loans |
30,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,794,700.00 |
| Deferred Income Tax Liabilities |
20,384,578.62 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
81,425,921.11 |
| Total Liabilities |
1,515,020,985.37 |
| Paid-In Capital(Or Share Stock) |
334,992,000.00 |
| Capital Surplus |
838,056,830.83 |
| Surplus Reserve |
164,138,392.60 |
| LESS:Treasury Stock |
11,077,650.68 |
| Undistributed Profits |
980,931,180.36 |
| Minority Stockholder's Interest |
200,618,800.20 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,310,254,583.64 |
| Owner's Equity（Stockholder's Equity） |
2,510,873,383.84 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,025,894,369.21 |
